Mar Masiá (M Masiá)

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Intimate Partner Violence

Cardiovascular Disease

Hiv Infected Patients

Rheumatoid Arthritis Patients

Top Venues

The Journal of antimicrobial chemotherapy

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Felix Gutiérrez, Marta Fernández-González, Christian Ledesma, María Losada-Echeberría, Enrique Barrajón-Catalán, Javier García-Abellán, Daria De Stefano, Leandro López, Melissa Bello-Perez, Sergio Padilla, Mar Masiá
Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Mar Masiá, José A García, Javier García-Abellán, Sergio Padilla, Marta Fernández-González, Vanesa Agulló, Maria José Gosalbes, Sonia Ruíz-Pérez, Paula Mascarell, Angela Botella, Félix Gutiérrez
Distinct gut microbiota signatures associated with progression of atherosclerosis in people living with HIV. The Journal of infectious diseases (2024)
Felix Gutiérrez, Leandro López, Carlos Galera, Juan Manuel Tiraboschi, Joseba Portu, Lucio J García-Fraile, Miguel García Del Toro, Enrique Bernal-Morell, Antonio Rivero, Javier García-Abellán, Juan Flores, Ana González-Cordón, Onofre Martínez, Joaquín Bravo Urbieta, Dácil Rosado, Marta Montero-Alonso, Guillem Sirera, Miguel Torralba González de Suso, Maria José Galindo, Juan Macías, Inmaculada Gónzalez, Vicente Boix, María Jesús Vivancos, Paula Dios, José-Ramon Blanco, Sergio Padilla, Marta Fernández-González, Ana Gutiérrez, Esteban Martínez, Mar Masiá, null null
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Marta Fernández-González, Vanesa Agulló, Jose Alberto Garcia-Gómez, Sergio Padilla, Javier García-Abellán, Alba de la Rica, Paula Mascarell, Mar Masiá, Felix Gutiérrez
T-cell immunity against SARS-CoV-2 measured by an interferon-γ release assay is strongly associated with patient outcomes in vaccinated persons hospitalized with Delta or Omicron variants. The Journal of infectious diseases (2023)
Daniel Podzamczer, Arkaitz Imaz, Ana Lopez-Lirola, Hernando Knobel, Mar Masiá, Chiara Fanciulli, Cristina Hernández, María Lagarde, Angela Gutierrez, Adrià Curran, Luis Morano, Marta Montero-Alonso, Jesús Troya García, Raúl Rigo, María Casadellà, Antonio Navarro-Alcaraz, Fernando Ardila, Mariona Parera, Enrique Bernal, Patricia Echeverria, Vicente Estrada, Carmen Hidalgo-Tenorio, Juan Macías, Paula Prieto, Joaquín Portilla, Eulalia Valencia, María Jesús Vivancos, Antonio Rivero
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens. The Journal of antimicrobial chemotherapy (2023)
Mar Masiá, Ana Gutiérrez-Ortiz de la Tabla, Félix Gutiérrez
Cancer screening in people living with HIV. Cancer medicine (2023)
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masiá, Mark Gompels, Stephane De Wit, Eric Florence, Stefan Esser, François Raffi, Georg Behrens, Anton Pozniak, Jose M Gatell, Esteban Martínez, null null
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir. The Journal of antimicrobial chemotherapy (2023)
Mar Masiá, Alba de la Rica, Marta Fernández-González, Jose Alberto Garcia-Gómez, Sergio Padilla, Javier García-Abellán, Ángela Botella, Paula Mascarell, Felix Gutiérrez
Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19. Microbiology spectrum (2023)
Mar Masiá, Marta Fernández-González, Vanesa Agulló, Paula Mascarell, Sergio Padilla, Javier García-Abellán, Félix Gutiérrez
HIV-1 RNA levels in rectal and seminal compartments after switching to long-acting cabotegravir plus rilpivirine: a longitudinal study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Maria Saumoy, Jose Luís Sánchez-Quesada, Lambert Assoumou, José Maria Gatell, Ana González-Cordón, Giovanni Guaraldi, Pere Domingo, Andrea Giacomelli, Jérôme Connault, Christine Katlama, Mar Masiá, Jordi Ordónez-Llanos, Anton Pozniak, Esteban Martínez, Daniel Podzamczer
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Sergio Padilla, Kristina Polotskaya, Marta Fernández-González, Nieves Gonzalo-Jiménez, Alba de la Rica, José Alberto García, Javier García-Abellán, Paula Mascarell, Felix Gutiérrez, Mar Masiá
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation. The Journal of antimicrobial chemotherapy 77 (8) (2022)
Jara Llenas-García, Mar Masiá, Reyes Pascual Perez, Inmaculada González-Cuello, Vanesa Agulló Re, Mónica Romero Nieto, María Amat Díaz, Sergio Padilla Urrea, Francisco José Rodríguez Lucena, Philip Erick Wikman Jogersen
Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study. AIDS care (2022)
Marta Fernández-González, Vanesa Agulló, Alba de la Rica, Ana Infante, Mar Carvajal, Jose Alberto Garcia-Gómez, Nieves Gonzalo-Jiménez, Claudio Cuartero, Montserrat Ruiz-García, Carlos de Gregorio, Manuel Sánchez, Mar Masiá, Felix Gutiérrez
Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter? Journal of clinical microbiology 59 (4) (2021)
Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A García, Vanesa Agulló, María Andreo, Sandra Ruiz, Antonio Galiana, Felix Gutiérrez, Mar Masiá
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. Journal of clinical immunology 41 (7) (2021)
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masiá, Mark Gompels, Stephane De Wit, Eric Florence, Stefan Esser, François Raffi, Georg Behrens, Anton Pozniak, José M Gatell, Esteban Martínez, null null
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Mar Masiá, Sergio Padilla, José A García, Javier García-Abellán, Marta Fernández-González, Ignacio Bernardino, Marta Montero, Joaquim Peraire, Berta Pernas, Félix Gutiérrez
Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015. PloS one 14 (4) (2019)
Mar Masiá, S Padilla, J A García, J I Bernardino, A A Campins, V Asensi, F Gutiérrez, null null
Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015. HIV medicine (2018)
Francisco Canals, Mar Masiá, Félix Gutiérrez
Developments in early diagnosis and therapy of HIV infection in newborns. Expert opinion on pharmacotherapy 19 (1) (2017)